Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Juhong Tanke Inhalation Solution is a traditional Chinese medicine (TCM) candidate being developed by Beijing Yingkerei Pharmaceutical Technology for the treatment of respiratory conditions, specifically cough and phlegm. The drug is a nebulized formulation of the classic Juhong Tanke formula, which traditionally utilizes Exocarpium Citri Grandis (Juhong) as its primary active component to resolve phlegm and suppress cough. By utilizing inhalation via nebulization as the route of administration, the therapy aims to deliver active herbal constituents directly to the lung tissue and airways, potentially increasing local drug concentration and efficacy while minimizing systemic side effects. It is currently in the preclinical stage of development.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Juhong Tanke Inhalation Solution.